Other benign neoplasm of corpus uteri
ICD-10 D26.1 is a billable code used to indicate a diagnosis of other benign neoplasm of corpus uteri.
D26.1 refers to other benign neoplasms located in the corpus uteri, which is the main body of the uterus. These neoplasms can include a variety of growths such as fibroids (leiomyomas), adenomyomas, and other non-cancerous tumors. While benign, these neoplasms can lead to significant symptoms including abnormal uterine bleeding, pelvic pain, and pressure symptoms. Diagnosis typically involves imaging studies such as ultrasound or MRI, and histological examination may be necessary for definitive diagnosis. Management options vary based on the size and symptoms of the neoplasm and may include watchful waiting, medical management with hormonal therapies, or surgical interventions such as myomectomy or hysterectomy. Follow-up care is essential to monitor for any changes in symptoms or growth of the neoplasm, and to ensure that no malignant transformation occurs. Regular gynecological examinations are recommended for women diagnosed with benign neoplasms of the uterus.
Detailed descriptions of the neoplasm, imaging results, and treatment plans.
Management of symptomatic fibroids, evaluation of abnormal uterine bleeding.
Ensure that all imaging and pathology reports are included in the medical record.
Clear imaging reports indicating the presence and characteristics of the neoplasm.
Ultrasound or MRI evaluations for suspected uterine neoplasms.
Accurate descriptions of the size, location, and characteristics of the neoplasm are crucial.
Used when a patient with a benign neoplasm requires surgical intervention.
Operative reports detailing the findings and reasons for surgery.
Gynecologists must ensure that the indication for surgery is clearly documented.
Common symptoms include abnormal uterine bleeding, pelvic pain, and pressure symptoms. Some patients may be asymptomatic.
Diagnosis is typically made through imaging studies such as ultrasound or MRI, and may require histological examination for confirmation.
Treatment options range from watchful waiting and medical management to surgical interventions such as myomectomy or hysterectomy, depending on the symptoms and size of the neoplasm.
